Advertisement
Singapore markets close in 5 hours 56 minutes
  • Straits Times Index

    3,292.98
    +20.26 (+0.62%)
     
  • Nikkei

    38,329.39
    +777.23 (+2.07%)
     
  • Hang Seng

    17,136.30
    +307.37 (+1.83%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,585.29
    -135.54 (-0.20%)
     
  • CMC Crypto 200

    1,433.97
    +19.21 (+1.36%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,334.40
    -7.70 (-0.33%)
     
  • Crude Oil

    83.36
    0.00 (0.00%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • FTSE Bursa Malaysia

    1,567.60
    +5.96 (+0.38%)
     
  • Jakarta Composite Index

    7,180.81
    +70.00 (+0.98%)
     
  • PSE Index

    6,574.68
    +67.88 (+1.04%)
     

Medtronic Earnings, Revenue Beat in Q1

Medtronic Earnings, Revenue Beat in Q1
Medtronic Earnings, Revenue Beat in Q1

Investing.com - Medtronic reported first quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.

The firm reported earnings per share of $1.26 on revenue of $7.49B. Analysts polled by Investing.com anticipated EPS of $1.18 on revenue of $7.4B. That compared to EPS of $1.17 on revenue of $7.38B in the same period a year earlier. The company had reported EPS of $1.54 on revenue of $8.15B in the previous quarter.

Medtronic follows other major Healthcare sector earnings this month

On July 30, Merck&Co reported second quarter EPS of $1.3 on revenue of $11.76B, compared to forecasts of EPS of $1.16 on revenue of $10.96B.

ADVERTISEMENT

Pfizer earnings beat analysts' expectations on July 29, with second quarter EPS of $0.8 on revenue of $13.26B. Investing.com analysts expected EPS of $0.75 on revenue of $13.4B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Tod's founder Della Valle further raises stake to 81.2%

U.S. yield curve: Invert, steepen, repeat

Home Depot Cuts Sales Outlook on Tariffs, Lumber Price Deflation